You searched for "MET"

725 results found

Factors and time to conversion from prostate cancer active surveillance to treatment

Active surveillance is the standard of care for men with low-risk and selected men with favourable intermediate risk prostate cancer. The aim is to reduce the morbidity and mortality of overtreatment of non-clinically significant prostate cancer. A significant proportion progress...

Catheters and incontinence after radical prostatectomy: Preparing (but not scaring) men

Every year about 6000 men in the UK undergo radical prostatectomy (RP) for treatment of prostate cancer [1]. Despite surgical advances, RP continues to be associated with significant side-effects including urinary incontinence (UI) [2]. Immediately following removal of the urinary...

Movember launches world’s largest cancer real world evidence network

Movember has launched the world’s largest prostate cancer and testicular clinical and research network, aimed at improving the overall survival and quality of life for those living with diseases that affect over 1.4 million men worldwide every year. The leading...

Prostate Cancer UK: Clinical Champions: Flagship long course (18 months) Deadline 2 Feb 2025 (Free)

Our award-winning long course, the Clinical Champions is all about driving change in your trust and broadening your professional soft-skill set. Our programme will support and inspire you to drive meaningful improvements for people living with or at risk of prostate cancer. To apply, you’ll need an improvement project and to demonstrate how you’d like to expand your leadership skills. As part of the programme you will receive: - Training on change leadership, system leadership, improvement science and implementing an improvement project. - Virtual improvement group meetings that allow time to connect with peers. - Individual support around your improvement ambitions and leadership development. - Opportunities to meet and network with inspiring leaders.

Prostate cancer management 2 – metastatic disease

A 72-year-old gentleman is referred to you in the two-week wait clinic with a prostate specific antigen (PSA) of 22ug/L. He is otherwise fit and well and does not take any regular medication. His multi-parametric magnetic resonance imaging (mpMRI) shows...

‘Man van’ launched to speed up cancer diagnosis and improve healthcare access

The ‘Man Van’, an innovative new outreach programme, was launched in March this year to provide free health checks for men and boost early diagnosis of prostate and other urological cancers. The mobile health clinic will visit workplaces and churches...

In conversation with Mr Duncan Summerton

Urology News was delighted to recently have a chat with Duncan Summerton, Consultant Urological Surgeon in Leicester and new President of BAUS. Duncan with a native wild brown trout caught on a dry fly on the Derbyshire Wye. Can you...

Improving on the Rotterdam Prostate Cancer Risk Calculator

Following the PROMIS trial [1], many cancer centres in the UK are now offering pre-biopsy multiparametric MRI (mpMRI) for men suitable for radical treatment. The European Association of Urology for Prostate Cancer (PCa) guidelines recommend individual risk stratification before the...

Using cryopreserved prepubertal testis tissues – are we getting warmer?

The rising incidence of childhood cancer coupled with increasing survivorship means there is a growing population of childhood cancer survivors with unmet health needs. In the UK around 1 in 500 children and young people are survivors of childhood cancer....

Peyronie’s disease: a review and update

Peyronie’s disease (PD) describes an acquired disease of the penis, which is characterised by a number of signs and symptoms. These include penile pain, curvature, palpable plaques, wasting or narrowing of the penile shaft, a hinge deformity and potentially catastrophic...

New analysis by Prostate Cancer UK uncovers inequalities in mortality and refutes prevailing beliefs

Prostate cancer mortality rates continue to be higher in Black men than white men, latest analysis reports. The disparity persists across all levels of deprivation, challenging beliefs that socioeconomic differences alone explain ethnic differences in outcomes. Even in the least...

MUC (Midlands Urology Club) Annual Meeting

The Midlands Urology Club (MUC) Meeting is back in Walsall this year. An eminent panel of Urologists will be talking to us on various aspects of clinical practice. Talks include updates from Mr A Birring & Mr KJ Ho on Genito-Urethral Reconstruction Services and Management of Penile Cancer in West Midlands, respectively. Mr C Luscombe will be leading a session on Implementation of the GIRFT A&G in the region. The event is fully subscribed now with LEDS, NTN’s, FYs & CTS as well as senior clinicians registered for the meeting. This is an opportunity to learn, get up-to-date on local practice and meet fellow colleagues in the area. Audits from various trusts in the region will be presented in the afternoon. Lunch and refreshments have kindly been provided by our sponsors.